Home
Precision BioLogic

Precision BioLogic Market Share Analysis for August 2026

CRYOcheck™ Chromogenic Factor VIII is a chromogenic assay for the determination of factor VIII activity in human plasma.

Industry: N/A

Domainprecisionbiologic.com

Year Founded1983

Employees51 - 200

Annual Revenue$5M - $10M

Precision BioLogic

Precision BioLogic (including company regionals)

precisionbiologic.com

See more website traffic and engagement information

Precision BioLogic Revenue up to August 2026 is 5M - 10M

revenue generated by Precision BioLogic top domains

Precision BioLogic top domains revenue over 3 years

Revenue for Precision BioLogic top domains

precisionbiologic.com5M - 10M

See more with Sales Intelligence

Total visits to Precision BioLogic's top domains

Understand Precision BioLogic market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

precisionbiologic.com--

See more with Sales Intelligence

Avg. visit duration in Precision BioLogic's top domains

Analyze Precision BioLogic engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

precisionbiologic.com--

See more with Sales Intelligence

Avg. pageviews on Precision BioLogic's top domains

See how Precision BioLogic keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

precisionbiologic.com--

See more with Sales Intelligence

Precision BioLogic top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Precision BioLogic

These are the website technologies, by industry, used by Precision BioLogic top domains

Advertising (5)

Google Adsense

Widget (4)

reCAPTCHA

Content Management System (3)

WordPress

Conversion & Analytics (3)

Google Analytics

More Technologies

8

See all

News & Signals from Precision BioLogic

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPrecision BioLogic Incorporated attended event ISTH 2026 on Jul 1st '26."We exhibited at ISTH 2026 in Paris this summer and fielded a lot of questions about our bovine Chromogenic Factor VIII and its ability to accurately measure factor VIII in the presence of not only extended half-life FVIII replacement products but also emerging FVIIIa mimetic bispecific antibodies," says Paul Empey, President and CEO of Precision BioLogic.

NewsPrecision BioLogic Incorporated acquired Kingbiomed on Oct 16th '25.HALIFAX, October 16, 2025 - Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the strategic acquisition of George King Bio-Medical, Inc., a provider of hemostasis diagnostic products with close ties to the bleeding disorders community.

NewsPrecision BioLogic Incorporated launches update of Cryocheck Chromogenic Factor VIII assay.Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the expanded utility of its CRYOcheck Chromogenic Factor VIII assay in anticipation of emerging hemophilia treatments such as Mim8, a next generation bispecific antibody for the treatment of hemophilia A.